NASDAQ:ESPR
Esperion Therapeutics Stock News
$2.08
+0.0200 (+0.97%)
At Close: May 03, 2024
Esperion Therapeutics (ESPR) Down 32.5% Since Last Earnings Report: Can It Rebound?
03:30pm, Saturday, 28'th Mar 2020
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Esperion announces data presentations of NEXLETOL, NEXLIZET Tablet ESPR
02:20pm, Saturday, 28'th Mar 2020
Esperion announces data presentations of NEXLETOL, NEXLIZET Tablet ESPR
Esperion Announces Three Data Presentations of the NEXLETOL™ (bempedoic acid) Tablet and the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC)
01:30pm, Saturday, 28'th Mar 2020
ANN ARBOR, Mich., March 28, 2020 -- Esperion (NASDAQ:ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of NEXLETOL and results from the Phase 2.
Esperion Announces Three Data Presentations of the NEXLETOL™ (bempedoic acid) Tablet and the NEXLIZET™ (bempedoic acid and ezetimibe) Tablet at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC)
01:30pm, Saturday, 28'th Mar 2020
ANN ARBOR, Mich., March 28, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of...
Esperion Announces Three Data Presentations of the NEXLETOL™ (bempedoic acid) Tablet and the ...
12:00am, Saturday, 28'th Mar 2020Marshall Wace North America L.P. Buys New Position in Esperion Therapeutics Inc (NASDAQ:ESPR)
11:00am, Thursday, 26'th Mar 2020
Marshall Wace North America L.P. bought a new stake in shares of Esperion Therapeutics Inc (NASDAQ:ESPR) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Co
Esperion Therapeutics (NASDAQ:ESPR) Shares Up 5.7%
08:26am, Thursday, 26'th Mar 2020
Shares of Esperion Therapeutics Inc (NASDAQ:ESPR) shot up 5.7% on Tuesday . The company traded as high as $39.39 and last traded at $37.77, 580,423 shares traded hands during mid-day trading. A declin
Ancora Advisors LLC Buys New Holdings in Esperion Therapeutics Inc (NASDAQ:ESPR)
09:08am, Wednesday, 25'th Mar 2020
Ancora Advisors LLC bought a new stake in Esperion Therapeutics Inc (NASDAQ:ESPR) in the fourth quarter, Holdings Channel reports. The institutional investor bought 2,250 shares of the biopharmaceutic
Esperion Therapeutics Gets Relative Strength Rating Upgrade
12:00am, Tuesday, 24'th Mar 2020Esperion announces presentations on NEXLETOL program, NEXLIZET study ESPR
11:49am, Monday, 23'rd Mar 2020
Esperion announces presentations on NEXLETOL program, NEXLIZET study ESPR
ANN ARBOR, Mich., March 23, 2020 -- Esperion (NASDAQ:ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of NEXLETOL and results from the Phase 2.
ANN ARBOR, Mich., March 23, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that two pooled analyses from four Phase 3 clinical trials of...
Esperion Announces Pooled Analyses from Phase ' LDL-C Lowering Development Program of the ...
12:00am, Monday, 23'rd Mar 2020Bank of Montreal Can Acquires 1,000 Shares of Esperion Therapeutics Inc (NASDAQ:ESPR)
09:30am, Sunday, 22'nd Mar 2020
Bank of Montreal Can boosted its holdings in Esperion Therapeutics Inc (NASDAQ:ESPR) by 36.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Esperion appoints Alan Fuhrman to board of directors ESPR
12:03pm, Wednesday, 18'th Mar 2020
Esperion appoints Alan Fuhrman to board of directors ESPR
